AMENDMENT No. 9, dated as of March 15, 2021 (this “Amendment”), to the Credit Agreement, dated as of May 7, 2015, by and among Horizon Therapeutics USA, Inc., a Delaware corporation (the “Borrower”), Horizon Therapeutics plc, an Irish public limited...Credit Agreement • March 15th, 2021 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • Delaware
CREDIT AGREEMENT originally dated as of May 7, 2015 (as amended by Amendment No. 1, dated as of October 25, 2016, as further amended by Amendment No. 2, dated as of March 29, 2017, as further amended by Amendment No. 3, dated as of October 23, 2017, as further amended by Amendment No. 4, dated as of October 19, 2018, and as further amended by Amendment No. 5, dated as of March 11, 2019, as further amended by Amendment No. 6, dated as of May 22, 2019, as further amended by Amendment No. 7, dated as of December 18, 2019 and as further amended by Amendment No. 8, dated as of August 17, 2020, this “Agreement”), among HORIZON THERAPEUTICS USA, INC. (f/k/a Horizon Pharma USA, Inc.), a Delaware corporation (“HPUI”), HORIZON THERAPEUTICS PLC, an Irish public limited company (f/k/a Horizon Pharma Public Limited Company) (“Irish Holdco”), the Subsidiary Guarantors (as such term is defined in Article I) party hereto, the LENDERS from time to time party hereto and CITIBANK, N.A., as Administrative
